Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program

• Kerri A. Nottage ,

  * E-mail: kerri.nottage@stjude.org

  Affiliation Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Jane S. Hankins,

  Affiliation Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Matthew Smeltzer,

  Affiliation Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Fawaz Mzayek,

  Affiliation Division of Epidemiology and Biostatistics, School of Public Health, University of Memphis, Memphis, Tennessee, United States of America

  ⨯
• Winfred C. Wang,

  Affiliation Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Banu Aygun,

  Affiliation Division of Pediatric Hematology/Oncology and Stem Cell Transplantation, Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States of America

  ⨯
• James G. Gurney

  Affiliations Division of Epidemiology and Biostatistics, School of Public Health, University of Memphis, Memphis, Tennessee, United States of America, Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯